Fortive (NYSE:FTV) reports bullish Q3 2026

Fortive reported Q3 2026 revenue of $1.11 billion, beating estimates by 3.3%, with adjusted EPS of $0.77, a 9.4% beat. Adjusted EBITDA was $339 million, an 8.4% beat. Management raised full-year adjusted EPS guidance to $3.12 at the midpoint, a 4% increase. Operating margin improved to 21.3% from 15.5% year-on-year, while free cash flow margin remained steady at 25.6%.

Original reporting
Published Oct 28, 2026, 12:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 12:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Fortive (NYSE:FTV) reports bullish Q3 2026 — source image
Decision brief

The 30-second read

$FTVBullishHigh
01

Why it matters

The combination of revenue and adjusted EPS beats, higher adjusted EBITDA versus consensus, and a raised full-year adjusted EPS midpoint suggests improved earnings power and supports a higher valuation multiple if investors believe the margin trend can persist.

02

Market read

This is a company-specific earnings and guidance update with explicit beat metrics and a raised full-year EPS target, making it actionable for near-term positioning.

03

What to watch

Traders may discount the print if free cash flow margin is not improving versus prior-year levels, despite the operating margin increase.

Relevance 9/10Novelty 9/10Timing: reported Q3 2026 results and raised full-year guidance (published 2026-10-28)

Background

Fortive is reporting its Q3 2026 operating performance versus S&P analysts’ consensus and updating full-year adjusted EPS guidance.

Company-level read

Ticker impact

$FTVBullishHigh confidence
Context

Fortive reported Q3 2026 revenue of $1.11B and adjusted EPS of $0.77, beating consensus, and raised full-year adjusted EPS guidance to $3.12.

Expected impact

Likely upward pressure as the market prices in higher full-year adjusted EPS and stronger operating margin momentum.

Evidence & confidence

The article discloses a same-period earnings/guidance print with explicit beat metrics and a raised full-year EPS midpoint, which typically drives near-term re-rating.

Market effects

Signals strength in industrial instrumentation/automation demand and margin resilience, which can modestly lift sentiment for similar industrial names.

Primarily US large-cap sentiment via a single-company earnings/guidance catalyst.

Limited direct global spillover beyond industrial cyclicality read-through.

Counterpoint

The guidance raise is only a 4% midpoint increase, so upside may be capped if investors expected a larger step-up or if margin expansion proves temporary.

Key entities

  • Fortive

    FTV reported Q3 2026 results and raised full-year adjusted EPS guidance to $3.12 at the midpoint.

Related articles

$FTVMed

Is Ingersoll Rand A Better Way Than Fortive To Own Industrial Demand?

Fortive (FTV) and Ingersoll Rand (IR) both raised 2026 forecasts. FTV increased adjusted EPS to $3.12, citing strong performance. IR raised revenue growth to 6.3% and EPS to $3.64, attributing it to lower tax rate and share count. FTV has higher margins (63.5%) and focuses on buybacks, while IR emphasizes aftermarket sales and acquisitions, with lower margins (43.1%).

$FTVMed

Mizuho raises Fortive stock price target to $55 on earnings beat

Mizuho raised its price target for Fortive (FTV) to $55 from $51, keeping an Underperform rating. Fortive reported adjusted EPS of $0.77, beating estimates of $0.71, with 13% YoY growth. Core growth was 7.2%, and adjusted EBITDA margin was 30.6%. The company raised its 2026 EPS guidance to $3.10-$3.14. The stock is up 16.5% YTD. Truist also raised its target to $65, citing strong growth and margins.

$FTVHighAI 8/10

Fortive Corp (FTV) (Q3 2026) Earnings Call Highlights: Fifth Straight Quarter

Fortive Corp (FTV) reported Q3 2026 earnings, highlighting a decline in adjusted gross margin to 63% due to product mix. The Advanced Healthcare Solutions segment saw EBITDA margin contract 230 bps. CEO Soroye expressed confidence in long-term growth despite inflationary pressures and a Q4 revenue headwind of $15-$20M. The company is investing in innovation and data center sales, with core growth tracking above 5% for the year.